For the current REF see the REF 2021 website REF 2021 logo

Output details

3 - Allied Health Professions, Dentistry, Nursing and Pharmacy

University of Surrey

Return to search Previous output Next output
Output 49 of 217 in the submission
Article title

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

Type
D - Journal article
Title of journal
The Lancet
Article number
-
Volume number
377
Issue number
9773
First page of article
1256
ISSN of journal
01406736
Year of publication
2011
URL
-
Number of additional authors
26
Additional information

The author made a substantial contribution to the conception and design of the study; to the organisation of the conduct of the study. The author helped critique the output for important intellectual content

Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
56
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-